Issue 218

Welcome back to E&O: Prescription Digital Therapeutics, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O: Rx Digital Therapeutics

Here's a quick rundown of things happening in FDA-regulated and pharma-focused digital health:

• Big news (for everyone but E&O readers) this week was Eli Lilly's official announcement of LillyDirect. E&O readers learned